|
 Sharapova, who tested positive for the banned drug meldonium at the
Australian Open in January, is facing a suspension of up to four
years by the International Tennis Federation (ITF) and has already
lost numerous sponsorships in the aftermath.
The former world number one thanked her fans for their "tremendous
outpouring of support" before launching into a critique of what she
believed were some inaccurate reports.
"A report said that I had been warned five times about the upcoming
ban on the medicine I was taking. That is not true and it never
happened," Sharapova wrote.
The 28-year-old Russian said she was making no excuses for not
knowing about the ban that went into effect on Jan. 1, but said that
after the first announcement, other notices were "buried in
newsletters, websites, or handouts."
"Again, no excuses, but it’s wrong to say I was warned five times,"
said Sharapova, who has said she took the drug for 10 years due to a
family history of heart issues and diabetes.
The World Anti-Doping Agency (WADA) added meldonium to their banned
substance list after concluding that it improves blood flow and
boosts exercise capacity.
[to top of second column] |
"I’m proud of how I have played the game. I have been honest and
upfront," Sharapova said.
"I look forward to the ITF hearing at which time they will receive
my detailed medical records.
"I hope I will be allowed to play again."
(Reporting by Larry Fine; Editing by Andrew Both)
[© 2016 Thomson Reuters. All rights
reserved.]
Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
